交通銀行(03328.HK)完成發行300億元人幣二級資本債券
交通銀行(03328.HK)公佈,近日在全國銀行間債券市場發行「交通銀行股份有限公司2022年第一期二級資本債券,並於今日(25日)發行完畢,發行規模300億元人民幣(下同),爲10年期固定利率品種,票面利率3.45%,在第5年末附有前提條件的發行人贖回權。本次債券募集資金在扣除發行費用後,將依據適用法律和監管部門的批準,全部用於補充本行二級資本。
於2021年3月24日,該行臨時股東大會審議批準了2022年底前發行不超過1,400億元或等值外幣二級資本債券的議案。該行已於2021年9月在全國銀行間債券市場發行300億元二級資本債券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.